drug
(bupropion hydrochloride + naltrexone) ER
Marketedupdated 3mo agoby Currax Pharmaceuticals LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval28 co-mentions · 14 sources
- drugbupropion hydrochloride ER14 co-mentions · 14 sources
- tagSmall Molecule14 co-mentions · 14 sources
- drugAUVELITY14 co-mentions · 14 sources
- drugbupropion14 co-mentions · 14 sources
- drugbupropion hydrochloride MR14 co-mentions · 14 sources
- drugbupropion hydrochloride SR14 co-mentions · 14 sources
- drugWELLBUTRIN SR14 co-mentions · 14 sources
indications
investigational
Obesity
all catalysts(0)
nothing on the calendar yet
Trials studying (bupropion hydrochloride + naltrexone) ER
- phase4Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity
- phase4Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.
- phase4A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 4, 2027
312 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Jul 2, 2034method-of-use (U-1583)US 10231964
- Jul 2, 2034method-of-use (U-1583)US 10828294
- Jul 2, 2034method-of-use (U-1583)US 10835527
- Jul 2, 2034method-of-use (U-1583)US 11998542
- Jun 25, 2033method-of-use (U-1583)US 9633575
- Jun 5, 2033method-of-use (U-1583)US 10403170
- Jun 5, 2033method-of-use (U-1583)US 11139056
- Jan 13, 2032method-of-use (U-1808)US 9248123
- Jan 10, 2031method-of-use (U-1583)US 110335434.5y
- Feb 2, 2030method-of-use (U-1639)US 89161953.5y
- May 29, 2029method-of-use (U-1583)US 113247412.8y
- Feb 3, 2029formulationUS 80887862.5y
- Nov 8, 2027method-of-use (U-1585)US 103073761.3y
- Nov 8, 2027method-of-use (U-1585)US 120487691.3y
- Nov 8, 2027method-of-use (U-1584)US 83187881.3y
- Nov 8, 2027method-of-use (U-1585)US 87220851.3y
- Nov 8, 2027method-of-use (U-1585)US 91258681.3y
- Jun 4, 2027method-of-use (U-1639)US 9107837312d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that